HBIO
Price
$0.45
Change
-$0.02 (-4.26%)
Updated
Jul 3 closing price
Capitalization
184.01M
32 days until earnings call
SERA
Price
$2.49
Change
+$0.04 (+1.63%)
Updated
Jul 3 closing price
Capitalization
303.83M
32 days until earnings call
Interact to see
Advertisement

HBIO vs SERA

Header iconHBIO vs SERA Comparison
Open Charts HBIO vs SERABanner chart's image
Harvard Bioscience
Price$0.45
Change-$0.02 (-4.26%)
Volume$628.68K
Capitalization184.01M
Sera Prognostics
Price$2.49
Change+$0.04 (+1.63%)
Volume$80.12K
Capitalization303.83M
HBIO vs SERA Comparison Chart in %
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. SERA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and SERA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (HBIO: $0.45 vs. SERA: $2.49)
Brand notoriety: HBIO and SERA are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HBIO: 4% vs. SERA: 16%
Market capitalization -- HBIO: $184.01M vs. SERA: $303.83M
HBIO [@Medical Specialties] is valued at $184.01M. SERA’s [@Medical Specialties] market capitalization is $303.83M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileSERA’s FA Score has 0 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • SERA’s FA Score: 0 green, 5 red.
According to our system of comparison, HBIO is a better buy in the long-term than SERA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 4 TA indicator(s) are bullish while SERA’s TA Score has 5 bullish TA indicator(s).

  • HBIO’s TA Score: 4 bullish, 5 bearish.
  • SERA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SERA is a better buy in the short-term than HBIO.

Price Growth

HBIO (@Medical Specialties) experienced а -11.51% price change this week, while SERA (@Medical Specialties) price change was +25.76% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

HBIO is expected to report earnings on Aug 06, 2025.

SERA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SERA($304M) has a higher market cap than HBIO($184M). SERA YTD gains are higher at: -69.410 vs. HBIO (-78.531). HBIO has higher annual earnings (EBITDA): 8.03M vs. SERA (-35.29M). SERA has more cash in the bank: 49.1M vs. HBIO (4.28M). SERA has less debt than HBIO: SERA (1.86M) vs HBIO (42.8M). HBIO has higher revenues than SERA: HBIO (112M) vs SERA (306K).
HBIOSERAHBIO / SERA
Capitalization184M304M61%
EBITDA8.03M-35.29M-23%
Gain YTD-78.531-69.410113%
P/E RatioN/AN/A-
Revenue112M306K36,601%
Total Cash4.28M49.1M9%
Total Debt42.8M1.86M2,304%
FUNDAMENTALS RATINGS
HBIO: Fundamental Ratings
HBIO
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HBIOSERA
RSI
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
67%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCGLF55.17N/A
N/A
Societe Generale
WHLT0.08N/A
N/A
Chase Packaging Corp.
TGDLF0.65N/A
N/A
TONGDAO LIEPIN GROUP
IFUUF5.40N/A
N/A
Infrastructure & Utilities NZ Ltd.
IDGAF0.09N/A
N/A
5TH PLANET GAMES

HBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HBIO has been loosely correlated with IRMD. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if HBIO jumps, then IRMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HBIO
1D Price
Change %
HBIO100%
-3.51%
IRMD - HBIO
53%
Loosely correlated
+0.42%
SGHT - HBIO
39%
Loosely correlated
+1.20%
A - HBIO
38%
Loosely correlated
+0.60%
ICUI - HBIO
36%
Loosely correlated
-0.54%
RVTY - HBIO
36%
Loosely correlated
+0.41%
More

SERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SERA has been loosely correlated with CNVVF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SERA jumps, then CNVVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SERA
1D Price
Change %
SERA100%
+1.63%
CNVVF - SERA
33%
Loosely correlated
N/A
UTMD - SERA
28%
Poorly correlated
+1.66%
HBIO - SERA
27%
Poorly correlated
-3.51%
AMIX - SERA
27%
Poorly correlated
-6.58%
RVTY - SERA
26%
Poorly correlated
+0.41%
More